Mechanistically, SPAG6 promoted the translocation of MYO1D from the cytoplasm to the cell membrane, thereby activating the PI3K/AKT and ERK signaling pathways, which ultimately accelerating AML cell proliferation and tumor progression. Here, SPAG6 is linked to acute myeloid leukemia.